#flozin
#Flozin vindication!
Hi Swapnil, as you may know 2 large RCTs, DAPA-PKD & STOP-PKD have secured academic funding to evaluate the use of SGLT2i in ADPKD. They are set to launch in 2026.

Upon completion, both trials will combine their datasets in a pooled analysis, called FLOZIN-PKD. Hope you like the name 😉
January 18, 2025 at 3:10 PM
Another feather in the cap! Benefits are endless. #flozin #SGLT2i #medsky #nephsky
November 17, 2024 at 1:05 PM
And as I shared with you earlier but now I will publicly GLP1 + flozin even in established DKD can really delay progression!!
September 30, 2026 at 10:51 PM
David Cherney presenting on Flozin (28) or no Flozin (14) with Semaglutide in REMODEL

With these Sample size numbers it’s a 🥱

#ISNWCN
March 28, 2026 at 7:03 AM
The first simultaneous publication from #ISNWCN

journals.lww.com/jasn/fulltex... in @asnpublications.bsky.social JASN

Atrasentan reduced proteinuria in IgAN even if on RASi + Flozin
March 29, 2026 at 5:22 AM
Wake up baby, new ADH research just dropped and it’s #Flozin related!
March 19, 2025 at 1:16 AM
100% David

We talk about 4 pillars for treatment of diabetic kidney disease

If we get G-force on time (+/- a flozin) that’s the only pillar you need!
September 30, 2026 at 10:46 PM
Hyperkalemia rates not lower with adding a flozin to the MRA 🤔

www.nejm.org/doi/full/10....

#ERA25
June 5, 2025 at 9:54 AM
Cool acronym of the day for a very cool Flozin trial

‘APPLE TREE’ for empa versus dapa

#NephSky

cc @christosargyrop.bsky.social
October 23, 2025 at 10:55 AM
Slidedeck from an internal presentation on diabetic kidney disease 👇

Nephrologist's take on the effect and impact of SGLT-2 inhibitors, GLP-1 RAs and ns-MRA on #Kidney Disease in people with #diabetes #flozin #sglt2i #MRA #GLP1RA
#MedEd #MedSky #NephSky

www.slideshare.net/slideshow/ne...
November 11, 2024 at 2:07 PM
#ThrowbackThursday

Mechanism of Flozin action

🔗 academic.oup.com/ajh/article/... 🔓

#EditorsChoice from the highly cited archive
September 4, 2025 at 11:52 AM
This "living" guideline document will unlive many people with diabetes if applied.

Why are guideline ppl addicted to sulfunylureas/nsulin/metformin ?

Those are useful to lower A1c from stratospheric levels, but if we are thinking hard outcomes improvement, the answer is #flozin & #glp1

#fail
August 15, 2025 at 12:46 PM
Rationale and Design

Platform trial with multiple interventions

Standard of care = RASi + Flozin! Excellent

#ISNWCN #NephSky

3/
February 16, 2025 at 2:51 PM
funnily the data/confidence in metformin use in CKD is coming just as flozin/GLP1s make it less relevant
November 23, 2024 at 12:39 PM
Today’s trials at #KidneyWk

In the morning a LBCT session at 10:30

featuring
PISCES (fish oil in dialysis!)
LIBERATE in AKI
Another AKI alerts from @fperrywilson.bsky.social
A Transplant trial
GLP1 and a Flozin analyses

And
November 7, 2025 at 10:39 AM
I use metformin in kidney transplant recipients as a first line agent in post-transplant diabetes when eGFR >30 😬

Then a flozin. Then a GLP-1 RA
All good 👍

#NephJC
April 16, 2025 at 1:24 AM
What do you think of mandating:

‘RASi + Flozin’ as background standard of care

Then drug versus an active comparator on top of SoC? (eg prednisone or budesonide)

#NephSky
October 4, 2025 at 3:52 PM
yup - after #KidneyWk 2020
Alicia McDonough and @juancarlosqvelez.bsky.social were calling them -gliflozins and -flozins so we went to the next step!
February 16, 2026 at 8:53 PM
Cana is the flozin pioneer who died of dysentery.
November 18, 2024 at 12:58 AM
Team potassium and coming off the bench players flozin, high dose diuretic, bicarb and k binder
January 17, 2025 at 6:43 AM
Jonathan Pollack, IgA nepropathy (pronounced EYE-gan) patient from St. Louis, currently enjoying being on a flozin plus all sorts of other medications to try and avoid being on a flozin and dialysis later on. No COI. JAFO today.

#NephJC
February 11, 2026 at 2:08 AM
But yes, I #agreewithScott - would add RASi + Flozin right away
January 15, 2025 at 11:33 AM
Hi Swapnil, as you may know 2 large RCTs, DAPA-PKD & STOP-PKD have secured academic funding to evaluate the use of SGLT2i in ADPKD. They are set to launch in 2026.

Upon completion, both trials will combine their datasets in a pooled analysis, called FLOZIN-PKD. Hope you like the name 😉
January 18, 2025 at 1:51 PM
The nice thing about knowing #rstats, is that one can often answer some clinical questions using public data. E.g. do I expect a benefit when combining #flozin and #Glp1RA in patients living with diabetes and kidney disease?
Let's use 👇from www.sciencedirect.com/science/arti... to answer the Q 1/
November 11, 2024 at 11:49 PM
Luckily they did the responsible thing and followed up with a larger case control study using ICES, now live at @jamacurrent.bsky.social Network Open

jamanetwork.com/journals/jam...

Statin + Flozin = same or lower rates of rhabdomyolysis! 😅

2/2
November 17, 2024 at 2:40 PM